Text Size
81 studies found for:    Open Studies | "Carcinoma, Ductal, Breast"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer
Conditions: Central Nervous System Metastases;   Invasive Ductal Breast Carcinoma;   Invasive Ductal Breast Carcinoma With Predominant Intraductal Component;   Invasive Lobular Breast Carcinoma;   Invasive Lobular Breast Carcinoma With Predominant in Situ Component;   Liver Metastases;   Lobular Breast Carcinoma in Situ;   Lung Metastases;   Male Breast Cancer;   Medullary Ductal Breast Carcinoma With Lymphocytic Infiltrate;   Mucinous Ductal Breast Carcinoma;   Papillary Ductal Breast Carcinoma;   Recurrent Breast Cancer;   Stage IV Breast Cancer;   Tubular Ductal Breast Carcinoma;   Tumors Metastatic to Brain
Interventions: Radiation: hyperfractionated radiation therapy;   Other: laboratory biomarker analysis;   Radiation: stereotactic radiosurgery
2 Recruiting Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer
Conditions: Inflammatory Breast Cancer;   Invasive Ductal Breast Carcinoma;   Invasive Lobular Breast Carcinoma;   Mucinous Ductal Breast Carcinoma;   Papillary Ductal Breast Carcinoma;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Tubular Ductal Breast Carcinoma
Intervention: Radiation: External beam radiation therapy
3 Recruiting Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast
Condition: Carcinoma, Ductal, Breast
Interventions: Radiation: Whole breast radiation therapy alone - Standard schedule;   Radiation: Whole breast radiation therapy alone - Shorter schedule;   Radiation: Whole breast RT plus tumour bed boost - Standard schedule;   Radiation: Whole breast RT plus tumour bed boost - Shorter schedule
4 Unknown † Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS)
Condition: Ductal Carcinoma In Situ
Interventions: Drug: Carboplatin i.d. Days 1 & 15;   Drug: Carboplatin i.d. Day 1; Normal Saline i.d. Day 15;   Drug: Normal Saline
5 Recruiting A Pilot Pre-operative Window Trial of Black Cohosh in Women With Ductal Carcinoma in Situ
Condition: Ductal Carcinoma in Situ
Intervention: Dietary Supplement: Black cohosh
6 Unknown † Single-arm Study of Photodynamic Laser Therapy Using Foscan for Non-curatively-resectable Bile Duct Carcinoma
Condition: Non-curative Resectable Bile Duct Carcinoma
Intervention: Drug: Temoporfin
7 Recruiting Intraoperative Imaging of Breast Cancer With Indocyanine Green
Conditions: Invasive Ductal Carcinoma;   Invasive Lobular Carcinoma;   Ductal Carcinoma
Intervention: Drug: Indocyanine Green
8 Recruiting Hedgehog Inhibition for Pancreatic Ductal Adenocarcinoma (PDAC) in the Preoperative Setting (HIPPoS)
Condition: Pancreatic Ductal Adenocarcinoma
Intervention: Drug: GDC-0449
9 Recruiting A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ
Condition: Ductal Carcinoma in Situ
Intervention: Drug: Polyphenon E
10 Recruiting Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Condition: Ductal Breast Carcinoma in Situ
Interventions: Biological: trastuzumab;   Radiation: radiation therapy;   Other: laboratory biomarker analysis
11 Recruiting Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
Conditions: Invasive Ductal Carcinoma;   Ductal Carcinoma in Situ
Intervention: Radiation: Intra-operative Radiation Therapy - IORT
12 Recruiting Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery
Conditions: Ductal Breast Carcinoma in Situ;   Estrogen Receptor-negative Breast Cancer;   Estrogen Receptor-positive Breast Cancer;   HER2-negative Breast Cancer;   Invasive Ductal Breast Carcinoma;   Lobular Breast Carcinoma in Situ;   Progesterone Receptor-positive Breast Cancer;   Stage I Breast Cancer;   Stage II Breast Cancer
Interventions: Procedure: therapeutic conventional surgery;   Radiation: radiation therapy;   Procedure: quality-of-life assessment
13 Recruiting Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy
Conditions: Ductal Breast Carcinoma in Situ;   Invasive Ductal Breast Carcinoma;   Invasive Lobular Breast Carcinoma;   Lobular Breast Carcinoma in Situ;   Recurrent Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer
Interventions: Behavioral: Behavioral dietary intervention;   Procedure: Therapeutic conventional surgery;   Radiation: Radiation therapy;   Other: Counseling intervention;   Procedure: Quality-of-life assessment
14 Recruiting Magnetic Resonance Thermal Image Guided Laser Interstitial Thermal Therapy in Treating Patients With Breast Cancer
Conditions: Ductal Breast Carcinoma in Situ;   Invasive Ductal Breast Carcinoma;   Stage IA Breast Cancer;   Stage IB Breast Cancer
Interventions: Procedure: magnetic resonance thermal imaging;   Procedure: laser interstitial thermal therapy
15 Recruiting Vitamin D3 (Vit D3) Supplementation and T Cell Immunomodulation in Patients With Newly Diagnosed Operative Invasive Ductal Breast Carcinoma
Condition: Newly Diagnosed Operative Invasive Ductal Breast Carcinoma Stage I-II
Intervention: Dietary Supplement: Vitamin D
16 Recruiting Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial)
Conditions: Carcinoma, Intraductal, Noninfiltrating;   DCIS;   Ductal Carcinoma In Situ
Interventions: Drug: Chloroquine Standard Dose (500mg/week);   Drug: Chloroquine Low Dose (250mg/week);   Procedure: Breast Biopsy
17 Recruiting Lapatinib in Treating Women With Ductal Carcinoma In Situ of the Breast
Conditions: Breast Cancer;   Ductal Breast Carcinoma in Situ
Interventions: Drug: lapatinib ditosylate;   Other: placebo;   Other: laboratory biomarker analysis
18 Recruiting Phase IV Trial to Evaluate Breast Brachytherapy Using the Mammosite-Ml®
Conditions: Breast Cancer;   Ductal Carcinoma in Situ
Intervention: Device: Mammosite ML
19 Not yet recruiting A Phase II Study of siG12D LODER in Combination With Chemotherapy in Patients With Unresectable Locally Advanced Pancreatic Cancer
Conditions: Pancreatic Ductal Adenocarcinoma;   Pancreatic Cancer
Interventions: Drug: siG12D LODER;   Drug: Gemcitabine or FOLFIRINOX
20 Recruiting Study Comparing Nanoparticle-based Paclitaxel With Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Patients With Early Breast Cancer (GeparSepto)
Conditions: Tubular Breast Cancer Stage II;   Mucinous Breast Cancer Stage II;   Breast Cancer Female NOS;   Invasive Ductal Breast Cancer;   Tubular Breast Cancer Stage III;   HER-2 Positive Breast Cancer;   Inflammatory Breast Cancer Stage IV;   Inflammatory Breast Cancer
Interventions: Drug: nab-Paclitaxel;   Drug: Paclitaxel
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years